Literature DB >> 20697949

Reflections on the research status of Kampo medicine: a most rewarding visit to Japan.

Hao Xu1, Hui-jun Yin.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20697949     DOI： 10.1007/s11655-010-0508-y

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


× No keyword cloud information.
  5 in total

1.  Chemical constituents of propolis from Myanmar and their preferential cytotoxicity against a human pancreatic cancer cell line.

Authors:  Feng Li; Suresh Awale; Hongyan Zhang; Yasuhiro Tezuka; Hiroyasu Esumi; Shigetoshi Kadota
Journal:  J Nat Prod       Date:  2009-07       Impact factor: 4.050

2.  Cinnamaldehyde induces endothelium-dependent and -independent vasorelaxant action on isolated rat aorta.

Authors:  Ayano Yanaga; Hirozo Goto; Takako Nakagawa; Hiroaki Hikiami; Naotoshi Shibahara; Yutaka Shimada
Journal:  Biol Pharm Bull       Date:  2006-12       Impact factor: 2.233

3.  Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.

Authors:  Suresh Awale; Feng Li; Hiroko Onozuka; Hiroyasu Esumi; Yasuhiro Tezuka; Shigetoshi Kadota
Journal:  Bioorg Med Chem       Date:  2007-10-05       Impact factor: 3.641

4.  Effects of keishibukuryogan on vascular function in adjuvant-induced arthritis rats.

Authors:  Kazuya Nozaki; Hirozo Goto; Takako Nakagawa; Hiroaki Hikiami; Keiichi Koizumi; Naotoshi Shibahara; Yutaka Shimada
Journal:  Biol Pharm Bull       Date:  2007-06       Impact factor: 2.233

5.  A Proteomic Approach for the Diagnosis of 'Oketsu' (blood stasis), a Pathophysiologic Concept of Japanese Traditional (Kampo) Medicine.

Authors:  Chinami Matsumoto; Tetsuko Kojima; Kazuo Ogawa; Satoshi Kamegai; Takuya Oyama; Yukari Shibagaki; Tetsuo Kawasaki; Hiroshi Fujinaga; Kozo Takahashi; Hiroaki Hikiami; Hirozo Goto; Chizuru Kiga; Keiichi Koizumi; Hiroaki Sakurai; Hiroshi Muramoto; Yutaka Shimada; Masahiro Yamamoto; Katsutoshi Terasawa; Shuichi Takeda; Ikuo Saiki
Journal:  Evid Based Complement Alternat Med       Date:  2007-06-15       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.